The present invention provides kits, methods and compositions for the treatment of obesity. The compositions herein contain a substantially pure preparation of at least one catecholic butane, including, for example, NDGA compounds in a pharmaceutically acceptable carrier or excipient. The catecholic butane such as NDGA or its derivatives are administered to one or more subjects in need of treatment.

 
Web www.patentalert.com

< Methods and compositions for delivery of catecholic butanes for treatment of diseases

< Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides

> (Polyalkoxy)sulfonate surface modifiers

> Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase

~ 00273